2nd Quarter - Report

BGR GOVERNMENT AFFAIRS for ADAMS RESPIRATORY THERAPEUTICS

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 18, 2008 $30,000 Replaced
2nd Quarter - Termination Amendment (No Activity) Oct 17, 2008 — Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Monitoring and guidance with regard to FDA enforcement action, DXM-related litigation

LobbyistCovered position, as disclosed
JENNIFER LARKIN LUKAWSKI See prior filing.
EDWARD ROGERS See prior filing.
SHALLA ROSS See prior filing.
ROBERT WOOD See prior filing.

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.